Access cutting-edge i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Boston location
Access i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. treatment provided free
Check if you qualify for this i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. clinical trial in Boston, MA
No-Cost Study Care
Local to Boston
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Phase 2 clinical trial will study RVP-001, a new manganese-based MRI contrast agent, in people who are known to have gadolinium-enhancing central nervous system (CNS) lesions, for example brain tumors or multiple sclerosis. The goal of this study is to assess safety, efficacy, and pharmacokinetics of RVP-001 at three dose levels. The study will also compare RVP-001 imaging to gadolinium-based contrast agent (GBCA) imaging. A single dose of RVP-001 will be administered to each subject. Subj
Sponsor: Reveal Pharmaceuticals Inc.
Yes, this clinical trial (NCT06322342) has an active research site in Boston, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. treatment options in Boston, MA, this clinical trial (NCT06322342) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Boston — not just this study.
Browse Heart Attack Trials in Boston →